查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1772190

美國多組體學服務市場規模、佔有率、趨勢分析報告：按服務、類型、應用、最終用途和細分市場預測，2025 年至 2033 年

U.S. Multiomics Services Market Size, Share & Trends Analysis Report By Services, By Type, By Application, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國多組體學服務市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國多組體學服務市場預計到2033年將達到16.6億美元，2025年至2033年期間的複合年成長率為17.10%。

隨著對整合生物數據的需求不斷成長，以更好地了解疾病並加速個人化治療的發展，市場正在迅速擴張。基因組學、代謝體學、代謝組學和轉錄組學等多體學技術的進步正在重塑癌症、神經退化性疾病和慢性病等複雜疾病的診斷和治療方式。研究經費的增加和精準醫療的興起是推動市場成長的主要因素。

人工智慧與機器學習的融合將進一步加速對複雜資料集的解讀，從而在藥物開發和臨床診斷中做出更快、更準確的決策。這些進步使研究人員能夠分析來自多個生物層面的大型整合資料集，從而全面了解疾病機制，並促進新生物標記的識別。

此外，多組體學在藥物開發、學術研究和臨床診斷等各個領域的應用日益廣泛，也推動了市場的成長。腫瘤學、神經病學和罕見疾病治療領域對個人化和標靶治療治療的需求，催生了對多組體學服務的強勁需求。隨著監管要求的不斷變化，各公司正在擴展其服務範圍，投資於旨在簡化研究和臨床工作流程的創新，並確保提供高品質、合規的多組體學服務。

隨著多體學技術的發展，美國多體學服務市場已做好準備，推動全球生物醫學研究、加速藥物研發，並改善精準醫療解決方案的患者預後。

美國多組體學服務市場報告重點

  • 從服務角度來看，研究服務將在2024年主導美國多組體學服務市場，佔67.44%的市場佔有率。研究人員正在利用多體學方法探索複雜的生物過程，發現新的生物標記物，並深入了解疾病機制。隨著腫瘤學、神經病學和罕見疾病等領域對全面、綜合的生物數據的需求日益成長，研究服務在推動科學知識和治療創新方面發揮核心作用。
  • 按類型分類，批量多組體學服務在2024年佔據了最大的市場佔有率，佔77.01%。這種主導地位歸因於藥物研發、生物標記開發和臨床診斷領域對大規模多體學分析日益成長的需求。批量多體學服務提供全面且可擴展的解決方案，用於分析大型資料集，整合基因組學、蛋白質組學和代謝體學資訊，以更好地理解複雜疾病。批量多組體學能夠以高精度和高效率處理大量數據，已成為製藥公司、研究機構和臨床實驗室的重要服務。
  • 從應用角度來看，2024年，藥物發現和開發佔據了美國多組體學服務市場的主導地位，佔據了35.52%的市場佔有率。多組體學正日益整合到藥物開發平臺中，從而能夠更準確地識別治療標靶、最佳化藥物配方，並更深入地了解藥物的療效和安全性。由於精準醫療（尤其是在腫瘤學、神經病學和免疫學領域）日益受到關注，該應用將繼續成為市場的關鍵驅動力。整體情況疾病機制並預測患者對治療的反應，可以提高藥物發現和臨床試驗的成功率。
  • 從最終用途來看，製藥和生物技術公司佔據主導地位，佔2024年美國多組體學市場佔有率的44.83%。這些公司在採用多組體學服務來支持藥物發現、生物標記開發和個人化醫療方面處於領先地位。對高品質、整合的多體學數據的需求對於簡化創新治療方法的開發和提高臨床試驗的準確性至關重要。製藥公司、生技公司和多體學服務提供者之間的持續合作正在加速下一代治療方法的開發，並擴大多體學在各個治療領域的應用。
  • 2025 年 4 月，Source Biosciences 將與 CCL 合作，加強其基因組檢測和精準醫療能力，以推進診斷解決方案並推動關鍵醫療保健創新。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國多組體學服務市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章美國多組體學服務市場：服務業務分析

  • 服務細分儀表板
  • 美國多組體學服務市場服務波動分析
  • 美國多體學服務市場規模與趨勢分析（按服務，2021-2033 年）
  • 研究服務
  • 數據分析服務

第5章美國多元組體學服務市場：按類型分類的業務分析

  • 類型細分儀表板
  • 美國多體學服務市場波動分析
  • 美國多體學服務市場規模與趨勢分析（按類型）（2021-2033）
  • 單細胞多組體學
  • 批量體學

第6章美國多組體學服務市場：應用業務分析

  • 應用程式細分儀表板
  • 美國多體學服務市場應用趨勢分析
  • 美國多體學服務市場規模與趨勢分析（按應用，2021-2033 年）
  • 生物標記發現市場
  • 藥物研發
  • 合成生物學
  • 其他

第7章美國多組體學服務市場：最終用途業務分析

  • 最終用途細分儀表板
  • 美國多組體學服務市場的最終用途趨勢分析
  • 美國多組體學服務市場規模和趨勢分析（按最終用途）（2021-2033 年）
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • Bio-Techne
    • CD Genomics
    • RayBiotech, Inc.
    • . Creative Proteomics
    • Psomagen
    • Source BioScience
    • Persistent Systems
    • Metware Biotechnology Inc.
    • Dalton Bioanalytics Inc.
    • Sapient Bioanalytics, LLC.
Product Code: GVR-4-68040-639-0

U.S. Multiomics Services Market Growth & Trends:

The U.S. multiomics services market is projected to reach USD 1.66 billion by 2033, growing at a CAGR of 17.10% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is expanding rapidly, driven by the growing demand for integrated biological data to enhance disease understanding and accelerate the development of personalized therapies. Advancements in multiomics technologies, such as genomics, proteomics, metabolomics, and transcriptomics, are reshaping how complex diseases, including cancer, neurodegenerative disorders, and chronic conditions, are diagnosed and treated. Increased research funding and the rise of precision medicine are key factors fueling the market's growth.

Integrating AI and machine learning further accelerates the interpretation of complex datasets, enabling faster, more accurate decision-making in drug development and clinical diagnostics. These advancements allow researchers to analyze large-scale, integrated datasets from multiple biological layers, offering a comprehensive view of disease mechanisms and facilitating the identification of new biomarkers.

The market's growth is also driven by the increasing application of multiomics across various sectors, including pharmaceutical development, academic research, and clinical diagnostics. The need for personalized and targeted therapies in oncology, neurology, and rare disease treatments has created a strong demand for multiomics services. With evolving regulatory requirements, companies are expanding their service offerings and investing in innovations that streamline the research and clinical workflows, ensuring high-quality and compliant multiomics services.

As multiomics technologies evolve, the U.S. multiomics services market is positioned to advance biomedical research, accelerate drug discovery, and improve patient outcomes in precision health solutions worldwide.

U.S. Multiomics Services Market Report Highlights:

  • By services, research services dominated the U.S. multiomics services market in 2024, accounting for 67.44% of the market share. Researchers are leveraging multiomics approaches to explore complex biological processes, discover new biomarkers, and gain deeper insights into disease mechanisms. As the need for comprehensive, integrated biological data grows in areas like oncology, neurology, and rare diseases, research services play a central role in advancing scientific knowledge and therapeutic innovation.
  • By type, bulk multiomics services held the largest market share in 2024, accounting for 77.01% of the market. This dominance can be attributed to the growing demand for large-scale multiomics analysis in drug discovery, biomarker development, and clinical diagnostics. Bulk multiomics services offer comprehensive, scalable solutions for analyzing large datasets, integrating genomics, proteomics, and metabolomics information to enhance understanding of complex diseases. The ability to handle large volumes of data with high precision and efficiency positions bulk multiomics as a key service offering for pharmaceutical companies, research institutions, and clinical labs.
  • By application, drug discovery & development dominated the U.S. multiomics services market in 2024, capturing 35.52% of the market share. Multiomics is increasingly being integrated into the drug development pipeline, allowing for more accurate identification of therapeutic targets, optimization of drug formulations, and a better understanding of drug efficacy and safety. This application continues to be a major driver in the market due to the growing focus on precision medicine, particularly in oncology, neurology, and immunology. The ability to provide a holistic view of disease mechanisms and predict patient responses to treatment enhances the success rate of drug discovery and clinical trials.
  • By end use, pharmaceutical & biotechnology companies dominated the U.S. multiomics services market in 2024, accounting for 44.83% of the market share. These companies are at the forefront of adopting multiomics services to support drug discovery, biomarker development, and personalized medicine. The demand for high-quality, integrated multiomics data is critical in streamlining the development of innovative therapies and improving the precision of clinical trials. Ongoing collaborations between pharmaceutical companies, biotechnology firms, and multiomics service providers are helping to accelerate the development of next-generation therapies and expand the applications of multiomics across various therapeutic areas.
  • In April 2025, Source BioScience collaborated with CCL to strengthen its genomic testing and precision medicine capabilities to advance diagnostic solutions and drive innovations in critical healthcare.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Multiomics Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Multiomics Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. U.S. Multiomics Services Market Service Movement Analysis
  • 4.3. U.S. Multiomics Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Research Services
    • 4.4.1. U.S. Research Services based Market, 2021 - 2033 (USD Million)
  • 4.5. Data Analysis Services
    • 4.5.1. U.S. Data Analysis Services Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Multiomics Services Market: Type Business Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. U.S. Multiomics Services Market Type Movement Analysis
  • 5.3. U.S. Multiomics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. U.S. Single-cell Multiomics Market, 2021 - 2033 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. U.S. Bulk U.S. Multiomics Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Multiomics Services Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. U.S. Multiomics Services Market Application Movement Analysis
  • 6.3. U.S. Multiomics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Biomarker Discovery Market
    • 6.4.1. U.S. Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery & Development
    • 6.5.1. U.S. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
  • 6.6. Synthetic Biology
    • 6.6.1. U.S. Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Multiomics Services Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. U.S. Multiomics Services Market End Use Movement Analysis
  • 7.3. U.S. Multiomics Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. U.S. Pharmaceutical and Biotechnology Companies Devices Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. U.S. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bio-Techne
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Service Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. CD Genomics
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Service Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. RayBiotech, Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Service Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. . Creative Proteomics
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Service Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Psomagen
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Service Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Source BioScience
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Service Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Persistent Systems
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Service Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Metware Biotechnology Inc.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Service Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Dalton Bioanalytics Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Service Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Sapient Bioanalytics, LLC.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Service Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 U.S. multiomics services market estimates & forecasts
  • Table 2 U.S. multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 3 U.S. multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 4 U.S. multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 5 U.S. multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 Participant categorization
  • Fig. 14 U.S. Multiomics Services market: Service outlook key takeaways
  • Fig. 15 U.S. Multiomics Services market: Service movement analysis
  • Fig. 16 Research Services market, 2021 - 2033 (USD Million)
  • Fig. 17 Data Analysis Services market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Multiomics Services market: Type outlook key takeaways
  • Fig. 19 U.S. Multiomics Services market: Type movement analysis
  • Fig. 20 Single-cell Multiomics market, 2021 - 2033 (USD Million)
  • Fig. 21 Bulk Multiomics market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Multiomics Services market: Application outlook key takeaways
  • Fig. 23 U.S. Multiomics Services market: Application movement analysis
  • Fig. 24 Biomarker Discovery market, 2021 - 2033 (USD Million)
  • Fig. 25 Drug Discovery & Development market, 2021 - 2033 (USD Million)
  • Fig. 26 Synthetic Biology market, 2021 - 2033 (USD Million)
  • Fig. 27 Others market, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Multiomics Services market: End Use outlook key takeaways
  • Fig. 29 U.S. Multiomics Services market: End Use movement analysis
  • Fig. 30 Academic & Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 31 Pharmaceutical and Biotechnology Companies market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 Key companies profiled